Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Europace ; 15(2): 212-8, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22968849

ABSTRACT

AIMS: We sought to characterise driving habits of contemporary implantable cardioverter defibrillator (ICD) patients. METHODS AND RESULTS: We performed a multicentre prospective observational study of consecutive ICD recipients. Non-commercial drivers with a valid licence were eligible. Patient and ICD data were recorded. All patients completed an anonymous questionnaire regarding their driving habits. Among 275 patients, 25 (9.1%) stopped driving permanently after ICD implantation. During a mean follow-up of 26.5 Ā± 4.5 months, 25.3% of patients received an ICD shock (52.5% appropriate). The median time to first shock was 7.0 (2.5, 17.5) months and was not significantly different between primary and secondary ICD patients. However, shocks (36.5 vs. 21.3%, P = 0.027) and recurrent shock episodes (17.5 vs. 6.2%, P = 0.011) were more common in secondary ICD patients. Physician-recommended driving restrictions were not recalled by 37.9% and not followed by 23.0% of patients. Overall, the mean duration of driving abstinence was 2.2 Ā± 2.9 and 3.6 Ā± 5.3 months for primary and secondary patients, respectively. Notably, 36.5% of secondary patients drove within 1 month. Eight patients (3.3%) received a shock while driving, five of which resulted in road traffic accidents. The annual risk of a shock while driving was 1.5%. CONCLUSIONS: Patient driving behaviour following ICD implantation is variable, with over one-third not remembering and almost one-quarter not adhering to physician-directed driving restrictions. Over one-third of secondary ICD patients drive within 1 month despite physician recommendations. Further studies are required to establish the optimal duration of driving restriction in ICD recipients.


Subject(s)
Accidents, Traffic/statistics & numerical data , Automobile Driving/statistics & numerical data , Defibrillators, Implantable/adverse effects , Defibrillators, Implantable/statistics & numerical data , Out-of-Hospital Cardiac Arrest/epidemiology , Out-of-Hospital Cardiac Arrest/therapy , Aged , Female , Humans , Ireland/epidemiology , Kaplan-Meier Estimate , Male , Middle Aged , Out-of-Hospital Cardiac Arrest/prevention & control , Prospective Studies , Risk Factors
2.
Am J Cardiol ; 96(2): 257-62, 2005 Jul 15.
Article in English | MEDLINE | ID: mdl-16018853

ABSTRACT

The prognostic values of tissue Doppler imaging and color M-mode diastolic indexes were studied in 225 patients who had symptomatic systolic heart failure in the ADEPT study. The primary end point of death, transplantation, or hospitalization due to heart failure occurred in 65 patients and was independently predicted by shorter deceleration time, lower ratio of pulmonary vein systolic to diastolic velocity, and increasing levels of the ratios of early transmitral velocity to early annular velocity or velocity of propagation. For the ratio of early transmitral velocity to early annular velocity, this prediction was additive to deceleration time. Newer diastolic indexes provide an independent prediction of clinical outcomes.


Subject(s)
Echocardiography, Doppler, Color/methods , Echocardiography, Doppler, Pulsed/methods , Heart Failure/diagnostic imaging , Ventricular Dysfunction, Left/diagnostic imaging , Age Factors , Aged , Female , Follow-Up Studies , Heart Failure/mortality , Heart Failure/physiopathology , Humans , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , Risk Assessment , Sensitivity and Specificity , Severity of Illness Index , Sex Factors , Survival Rate , Ventricular Dysfunction, Left/mortality , Ventricular Dysfunction, Left/physiopathology
3.
J Heart Lung Transplant ; 24(2): 229-30, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15701443

ABSTRACT

Refusal of treatment can have fatal consequences for heart failure patients who could otherwise benefit from ventricular assist device therapy. Ethical dilemmas arise when treatment refusals seem based on unsound reasoning by patients. Using a clinical case from our medical center, we explored the complex ethical issues associated with patient refusal of ventricular assist device therapy due to the patient's perception of large device size as compared to other mechanical heart technologies. Early on, the medical team must assess a patient's refusal of therapy by reflecting on the decisionmaking capacity of the patient to determine whether such refusal is truly "informed," and all incidents of informed refusal should be clearly documented in the patient's chart.


Subject(s)
Heart Failure/surgery , Heart-Assist Devices , Informed Consent/ethics , Treatment Refusal , Adult , Decision Making , Equipment Design , Ethics, Medical , Fatal Outcome , Humans , Male , Medical Futility , Patient Advocacy , Prognosis
4.
Am J Cardiol ; 93(11): 1443-4, A12, 2004 Jun 01.
Article in English | MEDLINE | ID: mdl-15165938

ABSTRACT

Two hundred sixty-three consecutive patients with hypertrophic cardiomyopathy underwent stress testing. Major complications occurred in 0.04% of patients and minor events occurred in 23%.


Subject(s)
Cardiomyopathy, Hypertrophic/diagnosis , Exercise Test , Contraindications , Echocardiography , Electrocardiography , Exercise Test/adverse effects , Female , Humans , Male , Middle Aged , Oxygen Consumption , Prospective Studies , Risk Factors , Safety , Ventricular Outflow Obstruction/diagnostic imaging
5.
Am J Cardiol ; 94(3): 409-11, 2004 Aug 01.
Article in English | MEDLINE | ID: mdl-15276123

ABSTRACT

Transthoracic echocardiography (TTE) is often technically difficult on patients in intensive care units. Contrast echocardiography can improve left ventricular wall visualization and the assessment of regional and global left ventricular wall motion. Our study undertook to determine what proportion of nondiagnostic TTE studies on patients in intensive care units could be salvaged (i.e., converted to diagnostic studies) with contrast. Ninety-two patients with nondiagnostic TTEs had a repeat study after contrast. Using predefined criteria, 51% of studies were salvaged with contrast. Female gender emerged as the only factor associated with less likelihood of salvaging a study.


Subject(s)
Contrast Media , Coronary Care Units , Echocardiography, Transesophageal/methods , Image Enhancement/methods , Ventricular Dysfunction, Left/diagnostic imaging , Aged , Echocardiography, Transesophageal/adverse effects , Female , Humans , Male , Middle Aged , Prospective Studies , Sensitivity and Specificity
6.
Am J Cardiol ; 94(7): 964-6, 2004 Oct 01.
Article in English | MEDLINE | ID: mdl-15464691

ABSTRACT

Real-time 3-dimensional echocardiography was performed in 10 patients with obstructive hypertrophic cardiomyopathy (HC) before and after myectomy and in 6 controls. The exact location of systolic anterior motion of the mitral leaflet was shown in all patients with HC with a predominant involvement of the medial portion in 4 patients and the middle portion in 6 patients. The smallest area of the left ventricular outflow tract was significantly smaller in patients with HC than in controls (1.4 +/- 0.7 vs 5.1 +/- 1.2 cm(2), p <0.01), significantly increased after myectomy (4.8 +/- 1.8 cm2, p <0.01) and was associated with a reduction of the pressure gradient at rest from 63 +/- 41 to 15 +/- 5 mm Hg (p <0.01).


Subject(s)
Cardiac Surgical Procedures , Cardiomyopathy, Hypertrophic/diagnostic imaging , Cardiomyopathy, Hypertrophic/surgery , Computer Systems , Echocardiography, Three-Dimensional , Adult , Aorta/diagnostic imaging , Aorta/physiopathology , Cardiac Catheterization , Cardiomyopathy, Hypertrophic/physiopathology , Echocardiography , Echocardiography, Doppler , Female , Heart Septum/diagnostic imaging , Heart Septum/physiopathology , Heart Ventricles/diagnostic imaging , Heart Ventricles/physiopathology , Humans , Male , Middle Aged , Mitral Valve Insufficiency/diagnostic imaging , Mitral Valve Insufficiency/physiopathology , Mitral Valve Insufficiency/surgery , Systole/physiology , Treatment Outcome , Ventricular Outflow Obstruction/diagnostic imaging , Ventricular Outflow Obstruction/physiopathology , Ventricular Outflow Obstruction/surgery
8.
Ann Thorac Surg ; 79(5): 1473-9, 2005 May.
Article in English | MEDLINE | ID: mdl-15854918

ABSTRACT

BACKGROUND: There is increasing interest in the role of valve repair for patients with isolated severe aortic regurgitation. Those with bicuspid aortic valves are suggested as most suitable for repair. Morphologic features of these valves that suggest feasibility of repair are not well defined. METHODS: Perioperative echocardiograms on 132 consecutive patients (mean age 42 +/- 12 years; 94% male), with bicuspid valves and isolated aortic regurgitation undergoing surgery at our institution were reviewed. Seventy-five patients (57%) underwent successful valve repair. Repair was attempted but unsuccessful for another 8 patients (6 intraoperatively and 2 before discharge). RESULTS: Cusp prolapse was the most common primary mechanism of regurgitation (88 patients [67%]), with 81 patients having primarily eccentrically directed regurgitation. Echocardiographic examination of 72 (55%) had evidence of cusp thickening with 40 (30%) having cusp calcification. By multivariate analysis, an eccentric regurgitant jet direction (odds ratio = 14.3; 95% confidence interval [CI] = 3.4 to 59.6), lack of cusp thickening (odds ratio = 5.9 [1.7 to 20]), lack of cusp calcification (odds ratio = 4.2; [1.1 to 16.7]) and the absence of commissural thickening (odds ratio = 4.8 [1.3 to 16.7]) were independently associated with a greater likelihood of successful valve repair. Greater cusp thickening was the only factor associated with attempted but failed repair. CONCLUSIONS: Successful repair of regurgitant bicuspid aortic valves was more feasible for those patients with eccentric regurgitant jets, those without cusp or commissural thickening or cusp calcification. Recognition of these features may enhance patient selection and improve procedural outcomes with aortic valve repair.


Subject(s)
Aortic Valve Insufficiency/surgery , Aortic Valve/surgery , Heart Valve Prosthesis Implantation/methods , Mitral Valve/surgery , Adult , Aortic Valve Insufficiency/diagnostic imaging , Dyspnea/etiology , Electrocardiography , Female , Heart Valve Prolapse/etiology , Humans , Male , Middle Aged , Patient Selection , Reproducibility of Results , Treatment Outcome , Ultrasonography
9.
Am J Transplant ; 4(7): 1200-3, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15196083

ABSTRACT

Human herpesvirus-6 (HHV-6), a beta herpesvirus closely related to cytomegalovirus (CMV), infects the majority of the population in childhood. Human herpesvirus-6 can be reactivated in the immunosuppressed patient. After bone marrow and orthotopic liver transplant, it has been linked to various clinical syndromes, including undifferentiated febrile illness, encephalitis, pneumonitis and bone marrow suppression. To date its infectious role after orthotopic heart transplant has not been well documented. We present the case of a 32-year-old cardiac transplant recipient who initially presented 8 weeks after his transplant with high fever and headache. He developed increasing confusion, pulmonary infiltrates and neutropenia. Cytomegalovirus viral loads were negative. Polymerase chain reaction (PCR) of blood and cerebrospinal fluid detected HHV-6 DNA, consistent with HHV-6-related encephalitis, pneumonitis and bone marrow suppression. He was treated with foscarnet with gradual improvement in clinical status. We review the literature on the significance of this virus post cardiac transplant.


Subject(s)
Encephalitis/etiology , Heart Transplantation/methods , Herpesviridae Infections/etiology , Herpesvirus 6, Human/metabolism , Adult , Antiviral Agents/pharmacology , Cytomegalovirus/metabolism , DNA, Viral/analysis , Encephalitis/pathology , Encephalitis/virology , Foscarnet/therapeutic use , Heart Transplantation/adverse effects , Humans , Immunosuppressive Agents/pharmacology , Leukocytosis/cerebrospinal fluid , Leukocytosis/metabolism , Male , Neutropenia/therapy , Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL